HomeACADEMIA
ACADEMIA

JSGO Will Revise Guidelines to Recommend Bevacizumab in Treatment of Stage IVB/Relapsed Cervical Cancer
(Jul.14.2016)

The Japan Society of Gynecologic Oncology (JSGO) announced at its scientific meeting held through July 10 that it plans to recommend the use of bevacizumab in its treatment guidelines for cervical cancer, which it will revise in 2017 ...
(LOG IN FOR FULL STORY)

News Calendar